日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis

3-羟基犬尿氨酸水平升高与人类急性胰腺炎的疾病严重程度相关

Christos Skouras, Xiaozhong Zheng, Margaret Binnie, Natalie Z M Homer, Toby B J Murray, Darren Robertson, Lesley Briody, Finny Paterson, Heather Spence, Lisa Derr, Alastair J Hayes, Andreas Tsoumanis, Dawn Lyster, Rowan W Parks, O James Garden, John P Iredale, Iain J Uings, John Liddle, Wayne L Wrig

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

抑制 PAD4 活性足以破坏小鼠和人类的 NET 形成

Huw D Lewis, John Liddle, Jim E Coote, Stephen J Atkinson, Michael D Barker, Benjamin D Bax, Kevin L Bicker, Ryan P Bingham, Matthew Campbell, Yu Hua Chen, Chun-Wa Chung, Peter D Craggs, Rob P Davis, Dirk Eberhard, Gerard Joberty, Kenneth E Lind, Kelly Locke, Claire Maller, Kimberly Martinod, Chris

Ideal anesthetic agents for day-care gynecological procedures: A clinical trial comparing thiopentone with ketamine as adjuncts to propofol

日间妇科手术的理想麻醉剂:一项比较硫喷妥钠和氯胺酮作为丙泊酚辅助药物的临床试验

Ahuja, Hemani; Abraham, Valsamma; Abraham, John; Liddle, Dootika

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

选择性 jumonji H3K27 去甲基化酶抑制剂调节促炎性巨噬细胞反应

Laurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, John Liddle, KaHing Che, Gerard Joberty, Marcus Bantscheff, Chas Bountra, Angela Bridges, Hawa Diallo, Dirk Eberhard, Sue Hutchinson, Emma Jones, Roy Katso, Melanie Leveridge, Palwinder K Mander, Julie Mosley, Cesar Ramirez-Molina, Paul Rowland, Chr

Configuration of a high-content imaging platform for hit identification and pharmacological assessment of JMJD3 demethylase enzyme inhibitors

配置高内涵成像平台用于 JMJD3 去甲基化酶抑制剂的鉴定和药理学评价

Alpa Mulji, Carl Haslam, Fiona Brown, Rebecca Randle, Bhumika Karamshi, Julia Smith, Robert Eagle, Jordi Munoz-Muriedas, Joanna Taylor, Arshad Sheikh, Angela Bridges, Kirsty Gill, Rob Jepras, Penny Smee, Mike Barker, Mike Woodrow, John Liddle, Pamela Thomas, Emma Jones, Laurie Gordon, Rob Tanner, Me

Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor

发现 GSK143,一种高效、选择性且口服有效的脾酪氨酸激酶抑制剂

John Liddle, Francis L Atkinson, Michael D Barker, Paul S Carter, Neil R Curtis, Rob P Davis, Clement Douault, Marion C Dickson, Dorothy Elwes, Neil S Garton, Matthew Gray, Thomas G Hayhow, Clare I Hobbs, Emma Jones, Stuart Leach, Karen Leavens, Huw D Lewis, Scott McCleary, Margarete Neu, Vipulkumar